Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Compugen Ltd. - Ordinary Shares
(NQ:
CGEN
)
1.740
-0.050 (-2.79%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Compugen Ltd. - Ordinary Shares
< Previous
1
2
3
4
5
Next >
Traders Insights: These Biotech Stocks On Radar: VSTM, SNTX, CGEN, SONN
June 05, 2023
Via
AB Newswire
Expert Ratings for Compugen
↗
May 26, 2023
Via
Benzinga
Compugen: Q1 Earnings Insights
↗
May 15, 2023
Via
Benzinga
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
↗
March 11, 2023
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the...
Via
Benzinga
Why Compugen Shares Are Up Today
↗
February 28, 2023
The company released its fourth-quarter and full-year results after the bell Monday.
Via
The Motley Fool
Earnings Preview: Compugen
↗
February 24, 2023
Via
Benzinga
Why Shares of Compugen Rose on Thursday
↗
December 29, 2022
The clinical-stage biotech retreated a bit from one of its biggest days in a while.
Via
The Motley Fool
Why Shares of Compugen Rose 16.5% on Wednesday
↗
November 30, 2022
Market factors and a company announcement helped the stock climb.
Via
The Motley Fool
Earnings Scheduled For February 27, 2023
↗
February 27, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.
Via
Benzinga
Why Compugen Stock Crumbled Today
↗
November 14, 2022
Investors indicated their displeasure with the company's recent fundamentals.
Via
The Motley Fool
Why Compugen Stock Got Slammed Today
↗
February 08, 2023
Clinical-stage biotechs are particularly susceptible to shifts in analyst sentiment.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For February 8, 2023
↗
February 08, 2023
Via
Benzinga
Why Shares of Compugen Jumped 17.86% on Thursday
↗
November 17, 2022
The company is receiving a $7.5 milestone payment from AstraZeneca for the use of one of its therapies.
Via
The Motley Fool
Why Shares of Compugen Jumped 9.27% on Tuesday
↗
November 01, 2022
The stock's rise came after the company announced when third-quarter earnings will be presented.
Via
The Motley Fool
Analyst Ratings for Compugen
↗
August 23, 2022
Within the last quarter, Compugen (NASDAQ:CGEN) has observed the following analyst ratings:
Via
Benzinga
Compugen: Q2 Earnings Insights
↗
August 04, 2022
Compugen (NASDAQ:CGEN) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
↗
January 05, 2023
Via
Benzinga
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
↗
November 18, 2022
Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday.
Via
Benzinga
5 Top Stocks Cathie Wood Sold This Week
↗
September 02, 2022
August was not a pleasant month for Cathie Wood and ARKK as the ETF experienced outflows of $803 million, the most since last September.
Via
InvestorPlace
Why Norwegian Cruise Line Shares Climbed By Around 12%; Here Are 66 Biggest Movers From Yesterday
↗
October 13, 2022
Gainers Pintec Technology Holdings Limited (NASDAQ: PT) shares jumped 216.2% to close at $0.9058 on Wednesday.
Via
Benzinga
Truist Securities Maintains Buy Rating for Compugen: Here's What You Need To Know
↗
August 23, 2022
Truist Securities has decided to maintain its Buy rating of Compugen (NASDAQ:CGEN) and lower its price target from $14.00 to $4.00. Shares of Compugen are trading up 2.29% over the last 24 hours, at...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
October 05, 2022
Wednesday saw 127 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
August 18, 2022
During Thursday's trading, 62 companies set new 52-week lows.
Via
Benzinga
Cathie Wood Scoops Up Over $20M Worth Of Fate Therapeutics Shares, Dumps More Twitter Stock
↗
August 12, 2022
Cathie Wood-led Ark Investment Management has bought 628,060 shares of clinical-stage biopharmaceutical company Fate Therapeutics Inc. (NASDAQ: FATE) through two of the firm’s exchange-traded funds...
Via
Benzinga
JMP Securities Maintains Market Outperform Rating for Compugen: Here's What You Need To Know
↗
August 08, 2022
JMP Securities has decided to maintain its Market Outperform rating of Compugen (NASDAQ:CGEN) and lower its price target from $8.00 to $4.00. Shares of Compugen are trading up 1.37% over the last 24...
Via
Benzinga
This Analyst Lowers Price Target On Lyft; Also Check Out Some Other Major PT Changes
↗
August 08, 2022
Wells Fargo cut the price target on Lyft, Inc. (NASDAQ: LYFT) from $49 to $42. However, Wells Fargo analyst Brian Fitzgerald maintained the stock with an Overweight. Lyft shares rose 0.6% to $20.41 in...
Via
Benzinga
Earnings Preview For Compugen
↗
August 03, 2022
Compugen (NASDAQ:CGEN) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that Compugen will...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
August 05, 2022
On Friday, 72 companies set new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
↗
August 05, 2022
Upgrades
Via
Benzinga
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday
↗
July 25, 2022
Gainers
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
